BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  BMS Backs Out of $1.5B Deal, Returns Rights to Agenus for Bispecific Antibody

  As part of a pipeline realignment, Bristol Myers Squibb is returning the rights to Agenus for its proprietary TIGIT bispecific antibody program and terminating their 2021 license, development and commercialization agreement.

  August 5, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Press Releases

  Niemann-Pick Disease Type C Market to Reach a CAGR of 16.9% during 2024-2034, Impelled by Cyclodextrin-Based Therapies

  August 5, 2024

   · 

  10 min read
• 

  Press Releases

  Neurotrophic Keratitis Market to Reach USD 248.0 Million by 2034, Impelled by Amniotic Membrane Transplantation

  August 5, 2024

   · 

  11 min read
• 

  Press Releases

  Medullary Thyroid Cancer Market to Reach USD 405.1 Million by 2034, Impelled by Targeted Radiation Therapies

  August 5, 2024

   · 

  10 min read
• 

  Press Releases

  Familial Adenomatous Polyposis Market to Reach a CAGR of 4.23% during 2024-2034, Impelled by the Increasing Application of Gene Therapy

  August 5, 2024

   · 

  10 min read
• Press Releases

  Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients

  August 5, 2024

   · 

  5 min read
• Press Releases

  Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful Results

  August 5, 2024

   · 

  15 min read
• Press Releases

  Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access

  August 5, 2024

   · 

  3 min read
• Press Releases

  Transforming Aesthetics: Dr. Maria Fedchuk’s Journey of Innovation at MTS US

  August 5, 2024

   · 

  5 min read
• Press Releases

  Sirtex Medical Launches SIR-Spheres® FLEXdose SELECT Delivery Program to Enable More Selective Y-90 Treatment Plans

  August 5, 2024

   · 

  2 min read